Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis

Interaction among variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1, and SLC9A3) and CFTR mutations with clinical markers of cystic fibrosis

“…In this context, our research group has been working to contribute to studies on numerous genes, which can act on drug response, inflammatory processes and the immune response to the pathogens that aggravate, mainly, the pulmonary disease …”